Among all the cancer cases, Lung cancer is the most common worldwide, which needs more potential therapy. But there are many limitations in the present therapy used for lung cancer treatment. Recently, many researchers are using different types of nanoparticles as an alternative for this purpose. Here, with such interest, ZnTe nanocrystals have been synthesized using a wet-chemical method, which is a cost-effective and easy method. After preparing the ZnTe nanocrystals, morphology has been analyzed through a scanning electron microscope (SEM) and the crystallinity of the prepared ZnTe nanocrystals has been investigated using X-ray diffraction analysis. After that, cytotoxicity of the prepared ZnTe nanoparticles has been examined at three different concentrations (100 ng/ml, 1 μg/ml, 100 μg/ml) on human lung cancer cell line L-132 using the MTT assay. From the experimental results, it is observed that a batter percentage of about 56 % of killing has been obtained at the concentration of 100 μg/ml after 24 h of treatment. It may happen that ZnTe nanoparticles enter through the cell membrane and induce cell apoptosis. For better understanding, molecular docking has been performed using ‘auto dock vina’ to find the binding confirmation of ZnTe nanoparticles with the lung cancer cell line L-132. Both the biological and computational methods confirm that nanocrystalline ZnTe is a therapeutic candidate for the treatment of lung cancer cells.
Read full abstract